Overall impact
C (56)

Commentary

Welcia is an average overall performer. With a 'C' rating of 56.4 for overall impact (55th percentile compared to all companies), Welcia ranks 8th out of 19 industry peers, behind HealthWarehouse.com, Trxade Group, Cosmos Pharmaceutical and 4 others, and ahead of GNC, Petmed Express, Portfolio and 8 others. On top material causes for Welcia's industry (Drug Retailers), Welcia performs well in Reduced Use of tobacco (82.5 score) and performs poorly in Zero Hunger (27.2 score), Child and Maternal Health (22.5), No Violence Against Women (21.3) and 2 other causes where it received a 'D' or 'F' score.
Impact
Cause 3141.T
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2008
Employees
16,611
Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Sub-industry
Drug Retail
SASB industry
Drug Retailers
Headquarters
Japan
Share classes
3141.T
Description
Welcia Holdings Co., Ltd., together with its subsidiaries, operates a chain of drug stores with dispensing pharmacies in Japan. Its stores offer OTC products, cosmetics, household goods, food, and other products. The company also offers counseling, late-night, and long-term care services, as well as home-visit bathing and nursing care support services, as well as housing services for elderly people. It also engages in the retail of daily necessities, foods, confectionary, alcohol, etc. The company was formerly known as Growell Holdings Co., Ltd. and changed its name to Welcia Holdings Co., Ltd. in September 2012. Welcia Holdings Co., Ltd. was founded in 1935 and is headquartered in Tokyo, Japan. Welcia Holdings Co., Ltd. is a subsidiary of Aeon Co., Ltd.
Material causes
Ethos considers the following causes material for Welcia, based on its industry sub-industry Drug Retail. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.